Nexpoint Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Nexpoint Asset Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-577,150	Closed	-$39.3M	–	180
2022 Q3	$39.3M	Buy	+577,150	New	+$31.8M	2.63%	12
2020 Q1	–	Sell	-16,200	Closed	-$1.29M	–	301
2019 Q4	$1.29M	Sell	16,200 -1,300	-7%	-$77K	0.1%	126
2019 Q3	$849K	Buy	+17,500	New	+$912K	0.05%	212

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Nexpoint Asset Management's GBT Position: Q4 2022 in Review

Nexpoint Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 577,150 shares — an estimated $39.3M sold.

Nexpoint Asset Management first reported a position in GBT in Q3 2019 and held it in 3 quarters. The position peaked at $39.3M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Nexpoint Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Nexpoint Asset Management sold 577,150 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $39.3M.
Nexpoint Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2019 and held it in 3 quarters.
Nexpoint Asset Management's Global Blood Therapeutics, Inc. position peaked at $39.3M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Nexpoint Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.